Skip to content
DAT Supply Log in
Botanicals · Gummies

Saffron Extract

INCI: Saffron Extract (Crocus sativus)

Saffron extract is a premium botanical ingredient derived from the stigma of Crocus sativus, standardised for bioactive compounds including crocin and safranal. It is one of the most familiar and commercially understood botanical actives across EU and US markets. As a botanical on the EFSA on-hold list, it carries no authorised EU health claims under Reg. 432/2012, so claim coverage for mood or emotional wellness typically relies on co-formulated nutrients such as Vitamin B6 or Folate.

  • mood-and-stress
  • premium-botanical
  • natural-wellness
Build a formula with this ingredient
Saffron Extract

At a glance

Definition
Saffron extract is a premium botanical ingredient derived from the stigma of Crocus sativus, standardised for bioactive compounds including crocin and safranal. It is one of the most familiar and commercially understood botanical actives across EU and US markets. As a botanical on the EFSA on-hold list, it carries no authorised EU health claims under Reg. 432/2012, so claim coverage for mood or emotional wellness typically relies on co-formulated nutrients such as Vitamin B6 or Folate.
Authorised wording (summary)
2 authorised statements — see "US structure-function statements" below.
Common positionings
  • mood support
  • stress resilience
  • emotional balance
  • cognitive wellness
  • premium natural ingredient
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Saffron extract is a premium botanical ingredient derived from the stigma of the Crocus sativus flower, commonly known as the saffron crocus. It is standardised for key bioactive compounds including crocin (responsible for colour), safranal (responsible for aroma), and picrocrocin (responsible for taste). In the nutraceutical industry, saffron extract is valued for its association with mood support, stress resilience, and emotional balance, making it a popular ingredient in premium wellness formulations.

Brands use saffron extract in gummy formats to differentiate their product range with a recognisable, high-value botanical. Its sweet aromatic profile and low effective dose (typically 15–30 mg per serving) make it well-suited for gummy manufacturing. As a botanical on the EFSA on-hold list, saffron extract does not carry authorised EU health claims under Reg. 432/2012, so brands typically position it around general wellness or combine it with co-formulated nutrients that have authorised claims for psychological function.

Origin and history

Saffron has been cultivated for over 3,500 years, with historical records tracing its use to ancient Greece, Persia, and the Mediterranean region. It has been used traditionally as a spice, a dye, and in herbal medicine systems for its association with mood and emotional well-being. The saffron crocus is a labour-intensive crop — each flower produces only three stigmas, which must be hand-harvested, making saffron one of the most expensive spices by weight.

Industrial production of saffron extract for the nutraceutical market involves harvesting the stigmas, drying them, and then extracting the bioactive compounds using solvents such as ethanol or water. The extract is then standardised to a guaranteed concentration of crocin and safranal, ensuring batch-to-batch consistency for supplement manufacturing. Today, the majority of commercial saffron is grown in Iran, with smaller production in Greece, Spain, and India.

Scientific overview

The primary bioactive compounds in saffron extract are crocin, safranal, and picrocrocin. Crocin is a carotenoid pigment that has been studied for its antioxidant properties and its potential role in supporting neurotransmitter activity. Safranal is a volatile compound responsible for saffron's distinctive aroma and has been investigated for its effects on the central nervous system. The combination of these compounds is thought to contribute to saffron's association with mood and emotional balance.

Bioavailability of saffron compounds varies. Crocin is water-soluble and has moderate oral bioavailability, while safranal is lipophilic and may be better absorbed with dietary fat. Standardised extracts typically contain 2% safranal and 20% crocin, providing a consistent profile for supplement manufacturers. The low effective dose (15–30 mg) makes saffron extract cost-efficient per serving despite its high raw material cost.

From a manufacturing perspective, saffron extract is heat-stable and soluble in gummy formulations, which simplifies processing. Its sweet aromatic taste is generally well-accepted in gummies at the low doses used. The primary manufacturing watchpoint is cost — saffron extract is a premium ingredient, and the cost-per-mg is significantly higher than most botanical extracts. Brands should confirm pricing and supply chain stability with their manufacturer before committing to a saffron-based product.

Why brands use Saffron Extract

Saffron extract occupies a premium positioning in the nutraceutical market, appealing to consumers seeking natural, plant-based ingredients for mood and stress support. It is one of the most familiar and commercially understood botanical actives across EU and US markets, which reduces the need for consumer education. Brands often position saffron gummies as part of a daily wellness routine, targeting adults looking for natural approaches to emotional balance and stress resilience.

From a formulation and manufacturing perspective, saffron extract is well-suited to gummies. It is heat-stable, soluble, and requires only a tiny microload per gummy (15–30 mg), which means it does not affect the gummy texture or size. The sweet aromatic taste is pleasant at these low doses, and no masking is typically required. The main tradeoff is cost — saffron extract is a premium ingredient, and the final gummy price point will reflect that. Brands should work with their manufacturer to confirm the cost-per-gummy and ensure it aligns with their target retail price.

For pack copy, brands must exercise claim discipline. Saffron extract has no authorised EU health claims under Reg. 432/2012. In the EU, brands may use general wellness positioning such as "mood support" or "emotional balance" but must avoid disease claims. Claim coverage for psychological function can come from co-formulated nutrients such as Vitamin B6 (contributes to normal psychological function) or Folate (contributes to normal psychological function). DAT reviews claim wording per project and market to ensure compliance. Certification status (vegan, kosher, halal, organic, non-GMO) depends on the selected raw material and supplier documentation — DAT confirms certification status per project and batch before final label claims. DAT confirms final shelf-life claims per project with stability data.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Premium

Forms available

  • Standardised saffron extract (typically 2% safranal, 20% crocin), saffron stigma powder

Dosage reference

Typical brand positioning range is 15–30 mg per serving. reference-intake target reviewed per market not established for saffron. DAT confirms dosing per project based on target market and claim strategy.

Taste & sensory

Sweet aromatic. Tiny gummy microload.

Manufacturing notes

Gummy-optimized dosing and format considerations.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

US structure-function statements

  • Supports mood and emotional balance.Structure-function (DSHEA)
  • Helps maintain a positive mood.Structure-function (DSHEA)

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

Wording to avoid on pack copy

  • No disease claims — cannot state or imply that saffron extract cures, prevents, or treats any disease.
  • Structure-function claims must be accompanied by the FDA disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
  • No certification promises on pack until confirmed per project and batch.
  • No guaranteed shelf-life on pack until confirmed with stability data.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Structure-function claims are permitted under DSHEA (21 USC §343(r)(6)). Daily Value (DV) for saffron extract has not been established under FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Lopresti AL, Drummond PD·Nutrients·2017

  2. Hausenblas HA, Saha D, Dubyak PJ, Anton SD·Journal of Integrative Medicine·2013

  3. Bathaie SZ, Mousavi SZ·Iranian Journal of Basic Medical Sciences·2010

  4. Khorasany T, Hosseinzadeh H·Avicenna Journal of Phytomedicine·2016

  5. EFSA NDA Panel·EFSA Journal·2020

Catalogue match

Product concepts featuring Saffron Extract

Private-label product concepts where Saffron Extract appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Pairs with 5-HTP (serotonin), Vitamin B6 (neurotransmitter), Folate (mood)

Care when combining with

Very expensive — premium ingredient. Mild serotonin activity. Safe.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Saffron Extract on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Saffron Extract.

Project handoff

Develop a formula featuring Saffron Extract

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.